A. Bibby

Most-cited papers

1. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

   Obbina Ali Fatima Mustafa Sadia Hakam Alfie Nabeel Ashraf Abani Abbas Abbas Abbas Abbasi Abbass Abbott Abdal, O. Abani, A. Abbas, F. Abbas +496 more

   2021The Lancet1,685 citations Open access

   Semantic Scholar

   Save

2. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort

   D. Arnold, F. Hamilton, A. Milne, Anna J. Morley +14 more

   2020Thorax548 citations Open access

   Semantic Scholar

   Save

3. British Thoracic Society Guideline for pleural disease

   M. Roberts, N. Rahman, N. Maskell, A. Bibby +18 more

   2023Thorax344 citations Open access

   Semantic Scholar

   Save

4. ERS/EACTS statement on the management of malignant pleural effusions

   A. Bibby, P. Dorn, I. Psallidas, J. Porcel +10 more

   2018European Respiratory Journal332 citations Open access

   Semantic Scholar

   Save

5. Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

   Eugenia Mustafa Sadia Alfie Ashraf Sherif Mohamed Basir Al Abaleke Abbas Abbasi Abbott Abdelaziz Abdelbadiee , E. Abaleke, M. Abbas, Sadia Abbasi +496 more

   2021The Lancet289 citations Open access

   Semantic Scholar

   Save

6. Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment

   A. Bibby, S. Tsim, N. Kanellakis, H. Ball +4 more

   2016European Respiratory Review283 citations Open access

   Semantic Scholar

   Save

7. Outpatient Talc Administration by Indwelling Pleural Catheter for Malignant Effusion

   R. Bhatnagar, E. Keenan, Anna J. Morley, B. Kahan +31 more

   2018New England Journal of Medicine231 citations Open access

   Semantic Scholar

   Save

8. British Thoracic Society Guideline for pleural disease

   M. Roberts, N. Rahman, N. Maskell, A. Bibby +18 more

   2023Thorax213 citations Open access

   Semantic Scholar

   Save

9. Recurrence rates in primary spontaneous pneumothorax: a systematic review and meta-analysis

   S. Walker, A. Bibby, P. Halford, L. Stadon +2 more

   2018European Respiratory Journal126 citations Open access

   Semantic Scholar

   Save

10. Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

    O. A. F. J. K. M. S. H. A. Abani Abbas Abbas Abbas Abbas Abbas Abbasi Abbass, O. Abani, A. Abbas, F. Abbas +496 more

    2023The Lancet103 citations Open access

    Semantic Scholar

    Save

11. ERS/EACTS statement on the management of malignant pleural effusions

    A. Bibby, P. Dorn, I. Psallidas, J. Porcel +10 more

    2018European Journal of Cardio-Thoracic Surgery81 citations Open access

    Semantic Scholar

    Save

12. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up; results from a prospective UK cohort.

    David T. Arnold, F. Hamilton, A. Milne, Anna J. Morley +14 more

    2020medRxiv61 citations Open access

    Semantic Scholar

    Save

13. Pleural biopsies in undiagnosed pleural effusions; Abrams vs image-guided vs thoracoscopic biopsies

    A. Bibby, N. Maskell

    2016Current opinion in pulmonary medicine48 citations Open access

    Semantic Scholar

    Save

14. Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

    Obbina Ali Fatima Mustafa Sadia Hakam Alfie Nabeel Ashraf Abani Abbas Abbas Abbas Abbasi Abbass Abbott Abdal, O. Abani, A. Abbas, F. Abbas +496 more

    2022The Lancet45 citations Open access

    Semantic Scholar

    Save

15. Survival in Patients With Malignant Pleural Effusions Who Developed Pleural Infection: A Retrospective Case Review From Six UK Centers.

    A. Bibby, A. Clive, G. Slade, Anna J. Morley +7 more

    2015Chest38 citations

    Semantic Scholar

    Save

16. The Prevalence and Clinical Relevance of Non-expandable Lung in Malignant Pleural Mesothelioma: A Prospective, Single-Center Cohort Study of 229 Patients.

    A. Bibby, P. Halford, D. de Fonseka, Anna J. Morley +2 more

    2019Annals of the American Thoracic Society29 citations Open access

    Semantic Scholar

    Save

17. Implementation of the NHS England Lung Cancer Screening Programme over 5 years

    R. Lee, Arjun Nair, H. Balata, Charlotte Graham +74 more

    2026Nature Medicine25 citations Open access

    Semantic Scholar

    Save

18. Inter‐observer variation in image interpretation and the prognostic importance of non‐expansile lung in malignant pleural effusion

    G. Martin, A. Kidd, S. Tsim, P. Halford +3 more

    2019Respirology (Carlton South. Print)25 citations Open access

    Semantic Scholar

    Save

19. Current treatments and trials in malignant pleural mesothelioma

    A. Bibby, N. Maskell

    2018Clinical Respiratory Journal21 citations

    Semantic Scholar

    Save

20. PET-CT-guided versus CT-guided biopsy in suspected malignant pleural thickening: a randomised trial

    D. de Fonseka, David T. Arnold, Helena Smartt, L. Culliford +18 more

    2023European Respiratory Journal19 citations Open access

    Semantic Scholar

    Save

21. What is the role of a specialist regional mesothelioma multidisciplinary team meeting? A service evaluation of one tertiary referral centre in the UK

    A. Bibby, Katie Williams, Sarah Smith, N. Bhatt +1 more

    2016BMJ Open16 citations Open access

    Semantic Scholar

    Save

22. Current best practice in the evaluation and management of malignant pleural effusions

    S. Walker, A. Bibby, N. Maskell

    2017Therapeutic Advances in Respiratory Disease14 citations Open access

    Semantic Scholar

    Save

23. The association between pleural fluid exposure and survival in pleural mesothelioma.

    R. Asciak, N. Kanellakis, A. Bibby, A. Kidd +8 more

    2021Chest13 citations Open access

    Semantic Scholar

    Save

24. Is systemic anticancer therapy associated with higher rates of malignant pleural effusion control in people with pharmacologically-sensitive tumours? A retrospective analysis of prospectively collected data.

    N. Holling, S. Patole, A. Medford, N. Maskell +1 more

    2021Chest12 citations

    Semantic Scholar

    Save

25. Commentary: considerations for using the ‘Trials within Cohorts’ design in a clinical trial of an investigational medicinal product

    A. Bibby, D. Torgerson, S. Leach, Helen Lewis-White +1 more

    2018Trials12 citations Open access

    Semantic Scholar

    Save

26. Physiological predictors of Hypoxic Challenge Testing (HCT) outcomes in Interstitial Lung Disease (ILD).

    S. Barratt, J. Shaw, Rachel Jones, A. Bibby +5 more

    2018Respiratory Medicine11 citations Open access

    Semantic Scholar

    Save

27. Exploring the characteristics of patients with mesothelioma who chose active symptom control over chemotherapy as first-line treatment: a prospective, observational, single centre study

    A. Bibby, D. de Fonseka, Anna J. Morley, E. Keenan +4 more

    2017BMC Palliative Care11 citations Open access

    Semantic Scholar

    Save

28. Ancillary Diagnostic Investigations in Malignant Pleural Mesothelioma

    A. Dipper, N. Maskell, A. Bibby

    2021Cancers10 citations Open access

    Semantic Scholar

    Save

29. Nutritional management in chyle leaks and chylous effusions.

    A. Bibby, N. Maskell

    2014British Journal of Community Nursing10 citations

    Semantic Scholar

    Save

30. Lymphocyte predominance in blood, pleural fluid, and tumour stroma; a prognostic marker in pleural mesothelioma

    D. de Fonseka, D. Arnold, Anna J. Morley, M. Brett +5 more

    2021BMC Pulmonary Medicine9 citations Open access

    Semantic Scholar

    Save

31. Benign pleural schwannoma presenting with a large, blood-stained pleural effusion

    A. Bibby, R. Daly, E. Internullo, A. Edey +1 more

    2017Thorax9 citations Open access

    Semantic Scholar

    Save

32. Is MMR immunisation safe in chronic Idiopathic thrombocytopenic purpura?

    A. Bibby, A. Farrell, M. Cummins, M. Erlewyn-Lajeunesse

    2008Archives of Disease in Childhood9 citations

    Semantic Scholar

    Save

33. The mental health and well-being implications of a mesothelioma diagnosis: A mixed methods study.

    Virginia Sherborne, Emily Wood, C. Mayland, Clare Gardiner +5 more

    2024European Journal of Oncology Nursing8 citations Open access

    Semantic Scholar

    Save

34. Reflecting real-world patients with mesothelioma in research: an interim report of baseline characteristics from the ASSESS-meso cohort

    R. Conway, Natalie Smith, W. Cooper, Geraldine A. Lynch +5 more

    2023ERJ Open Research7 citations Open access

    Semantic Scholar

    Save

35. The priorities of people with mesothelioma and their carers: A qualitative interview study of trial participation and treatment decisions.

    A. Bibby, Anna J. Morley, E. Keenan, N. Maskell +1 more

    2022European Journal of Oncology Nursing7 citations Open access

    Semantic Scholar

    Save

36. Protocol for a prospective observational cohort study collecting data on demographics, symptoms and biomarkers in people with mesothelioma (ASSESS-meso)

    R. Conway, J. Symonds, Deborah A. Walton, J. Probets +6 more

    2022BMJ Open6 citations Open access

    Semantic Scholar

    Save

37. Standards of care in mesothelioma treatment

    S. Harden, L. Darlison, P. Beckett, A. Bibby

    2020British Journal of Cancer6 citations Open access

    Semantic Scholar

    Save

38. Are intra-pleural bacterial products associated with longer survival in adults with malignant pleural effusions? A systematic review.

    A. Bibby, S. Walker, N. Maskell

    2018Lung Cancer6 citations Open access

    Semantic Scholar

    Save

39. Medical and oncological management of malignant mesothelioma.

    A. Bibby, L. Gibbs, J. Braybrooke

    2015British journal of hospital medicine6 citations

    Semantic Scholar

    Save

40. Checkpoint inhibitors in mesothelioma: hope for the future?

    A. Bibby, N. Maskell

    2019The Lancet Oncology5 citations Open access

    Semantic Scholar

    Save

41. Serum mesothelin as a response biomarker in pleural mesothelioma.

    Geraldine A. Lynch, J. Symonds, Anna J. Morley, Emeka Azubuike-Dyer +8 more

    2025Lung Cancer4 citations Open access

    Semantic Scholar

    Save

42. Recent Advances in Mesothelioma

    Geraldine A. Lynch, N. Maskell, A. Bibby

    2024Current Pulmonology Reports4 citations Open access

    Semantic Scholar

    Save

43. A trial of intra-pleural bacterial immunotherapy in malignant pleural mesothelioma (TILT) — a randomised feasibility study using the trial within a cohort (TwiC) methodology

    A. Bibby, N. Zahan-Evans, E. Keenan, C. Comins +6 more

    2021Pilot and Feasibility Studies3 citations Open access

    Semantic Scholar

    Save

44. Utility of illness severity scores to predict mortality in patients hospitalised with respiratory deterioration of Idiopathic Pulmonary Fibrosis.

    Catherine Hyams, D. Hettle, A. Bibby, H. Adamali +1 more

    2020QJM : monthly journal of the Association of Physicians3 citations Open access

    Semantic Scholar

    Save

45. Pleural procedures: intercostal chest drains and indwelling pleural catheters.

    A. Bibby, N. Maskell

    2011British journal of hospital medicine2 citations

    Semantic Scholar

    Save

46. Managing pleural malignancy

    Geraldine A. Lynch, A. Bibby, N. Maskell

    2023Medicine1 citations

    Semantic Scholar

    Save

47. The Priorities of People with Mesothelioma: A Qualitative Study of Trial Participation and Treatment Decisions

    A. Bibby, Anna J. Morley, E. Keenan, N. Maskell +1 more

    20211 citations Open access

    Semantic Scholar

    Save

48. Mesothelioma: is chemotherapy alone a thing of the past?

    A. Bibby, K. Blyth, D. Sterman, A. Scherpereel

    2020Pleural Disease1 citations Open access

    Semantic Scholar

    Save

49. Is pleural infection associated with longer survival in mesothelioma? A population-based cohort study using data from Hospital Episode Statistics.

    A. Bibby, D. de Fonseka, D. Carslake, N. Maskell

    2019Cancer Epidemiology1 citations Open access

    Semantic Scholar

    Save

50. Understanding pain in malignant mesothelioma: a prospective, longitudinal cohort study

    C. Mayland, M. Collinson, Sam H. Ahmedzai, Joseph E. Lucas +8 more

    2026BMC Palliative Care0 citations Open access

    Semantic Scholar

    Save